Together with a recent report of no loss of ATRX or DAXX expression by IHC in 58 grade II and III meningiomas [16], these results provide evidence that the ALT pathway is not a frequent mechanism for telomere maintenance in progressive higher-grade meningiomas. The gene discussed is ATRX; the disease is meningioma.